• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.

作者信息

Hart C A, Percival A

出版信息

J Antimicrob Chemother. 1983 Jan;11 Suppl:95-101. doi: 10.1093/jac/11.suppl_a.95.

DOI:10.1093/jac/11.suppl_a.95
PMID:6573329
Abstract

The activity of the 7 alpha-methoxycephalosporin, cefotetan was determined against 365 infecting isolates of gentamicin- and multiply-resistant Gram-negative aerobic bacilli, and compared with those of cefuroxime, cefoxitin, cephradine, cefotaxime, ceftriaxone and ceftazidime. All proteus (4), providencia (6) salmonella (3) and serratia (2) were susceptible to 8 mg/l of cefotetan, as were respectively 90 and 81% of 42 Escherichia coli and 16 citrobacter isolates. The intrinsic activity of cefotetan was high against 237 klebsiellae (38 different serotypes), only 4 being relatively insusceptible (MICs 16- greater than 32 mg/l). Activity against pseudomonas (10 isolates) acinetobacter (15 isolates) and enterobacter (30 isolates) was poor. Overall, the activities of cefotetan were similar to those of cefotaxime, ceftriaxone and ceftazidime but ceftazidime was also active against the majority of pseudomonas, acinetobacter and enterobacter. Cefotaxime was less active than cefotetan against some cefuroxime-resistant klebsiellae. Much greater numbers of isolates were insusceptible to either cefuroxime or cefoxitin. Cephradine was the least active.

摘要

相似文献

1
Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
J Antimicrob Chemother. 1983 Jan;11 Suppl:95-101. doi: 10.1093/jac/11.suppl_a.95.
2
In-vitro activity of cefotetan, other beta-lactams and netilmicin.
J Antimicrob Chemother. 1983 Jan;11 Suppl:73-8. doi: 10.1093/jac/11.suppl_a.73.
3
Cefotetan: profile of in-vitro activity.头孢替坦:体外活性概况。
J Antimicrob Chemother. 1983 Jan;11 Suppl:19-29. doi: 10.1093/jac/11.suppl_a.19.
4
Cefotetan: comparative study in vitro against 226 Gram-negative clinical isolates.
J Antimicrob Chemother. 1983 Jan;11 Suppl:31-6. doi: 10.1093/jac/11.suppl_a.31.
5
Comparative susceptibilities of organisms isolated in Sicily to cefotetan and other antibiotics.
J Antimicrob Chemother. 1983 Jan;11 Suppl:79-85. doi: 10.1093/jac/11.suppl_a.79.
6
In-vitro activity of cefotetan and other cephalosporins against multiresistant strains of Enterobacteriaceae.
J Antimicrob Chemother. 1983 Jan;11 Suppl:103-5. doi: 10.1093/jac/11.suppl_a.103.
7
In vitro comparison of cefotetan with five other cephalosporins against nosocomial pathogens.头孢替坦与其他五种头孢菌素对医院病原体的体外比较。
Chemotherapy. 1982;28(5):351-4. doi: 10.1159/000238104.
8
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.羟羧氧酰胺菌素和头孢噻肟对需氧革兰氏阴性杆菌的体外活性
Antimicrob Agents Chemother. 1980 Jun;17(6):937-42. doi: 10.1128/AAC.17.6.937.
9
Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
J Antimicrob Chemother. 1983 Jan;11 Suppl:11-7. doi: 10.1093/jac/11.suppl_a.11.
10
In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds.新型头孢霉素衍生物头孢替坦的体外活性与其他β-内酰胺类化合物的比较。
Antimicrob Agents Chemother. 1982 Mar;21(3):486-91. doi: 10.1128/AAC.21.3.486.

引用本文的文献

1
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use.头孢曲松。对其抗菌活性、药理特性及治疗用途的综述。
Drugs. 1984 Jun;27(6):469-527. doi: 10.2165/00003495-198427060-00001.
2
Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.头孢替坦:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1985 Nov;30(5):382-426. doi: 10.2165/00003495-198530050-00002.